Feminist critiques of menopause have been beneficial in opening up important public health debates around menopause. One of the most contentious public health issues concerns the use of Hormone Replacement Therapy (HRT) for the prevention of osteoporosis, heart disease and, more recently, Alzheimer's disease, in postmenopausal women. For preventive purposes, it is recommended that women should take HRT for 10-15 years and preferably remain on the therapy for the remainder of their lives. This is despite reported increased cancer risks associated with HRT, side effects and considerable cost of the therapy. Various studies have shown that up to 50% of women stop taking HRT after 9-12 months. These figures are used in the medical literature as an indication of women's non-compliance. Extending earlier feminist critiques around menopause and HRT, this paper discusses a critical feminist engagement around issues of women's perceived non-compliance with HRT.
Barrett-Connor E.Hormone replacement therapyBr Med J1998; 317: 457-61.
2.
Genazzani AR , Gambacciani M.Hormone replacement therapy: the perspectives for the 21st centuryMaturitas1999; 32: 11-7.
3.
Yaffe K., Sawaya G., Lieberburg I., Grady D.Estrogen therapy in postmenopausal women: effects on cognitive function and dementiaJAMA1998; 279: 688-95.
4.
Hulley S., Grady D., Bush T., Urberg C., Herrington D., Riggs B., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/ progestin Replacement Study (HERS) Research GroupJAMA1998; 280: 605-13.
5.
Coney S.The menopause industry. A guide to medicine's ``discovery'' of mid-life women . Auckland: Penguin, 1991.
6.
Wren B.HRT benefits both women and societyAustralian Doctor, 1993; 10: 13.
7.
Grady D., Cummings S., Petitti D., Rubin S., Audet AMGuidelines for counselling postmenopausal women about preventive hormone therapyAnn Intern Med, 1992; 117: 1038-41.
8.
Coope J., Marsh J.Can we improve compliance with long-term HRT?Maturitas, 1992; 15: 151-8.
9.
Rebar RW, Thomas MA, Gass ML, Liu JHProblems of hormone therapy: evaluations, follow up, complications. In: Korenman SG, editor. The menopause. Biology and clinical consequences of ovarian failure. Evolution and management . Norwell, MA: Serono Symposia, 1990: 145-56, 1992.
10.
Silverman SL, Greenwald M., Huberman A.Decisions on menopausal therapy. In: Korenman SG, editor. The menopause. Biology and clinical consequences of ovarian failure. Evolution and management. Norwell, MA: Serono Symposia, 1992: 129-44.
11.
Rozenberg S. , Vandromme J., Kroll M., Twagirayezu P., Vyankandondera J.Compliance with hormonal replacement therapyRev Med Brux, 1995; 16: 295-8.
12.
Marieskind H.The women's health movementInt J Health Serv, 1975; 5: 217-27.
13.
Broom DHDamned if we do. Contradictions in women's health care. Sydney: Allen & Unwin, 1991.
14.
Grosz E.Volatile bodies. Toward a corporeal feminism. Bloomington /Indianapolis: Indiana University Press, 1994.
15.
Grosz E.Inscriptions and body maps: representations and the corporeal. In: Threadgold T, Cranny-Francis A, editors. Feminine/masculine and representation. Sydney: Allen & Unwin, 1990: 62-74.
16.
Butler J.Gender trouble: feminism and the subversion of identity. New York: Routledge, 1990.
17.
Gatens M.Towards a feminist philosophy of the body. In: Caine B, Grosz E, Lepervanche Md, editors. Crossing boundaries. Feminisms and the critique of knowledges. Sydney: Allen & Unwin, 1988: 59-70.
18.
McKinlay SM, McKinlay JBSelected studies of the menopauseJ Biosoc Sci, 1973; 5: 533-55.
19.
Posner J.It's all in your head: feminist and medical models of menopause (strange bedfellows)Sex Roles, 1979; 5: 179-90.
20.
Swartzman LC, Leiblum S.Changing perspectives on the menopause J Psychosom Obstet Gynaecol, 1987; 6: 11-24.
21.
Lewis J.Feminism, the menopause and hormone replacement therapyFeminist Review, 1993; 43: 38-56.
22.
Bell SEChanging ideas: the medicalization of menopauseSoc Sci Med , 1987; 24: 535-42.
23.
Bell SESociological perspectives on the menopauseAnn N Y Acad Sci , 1990; 592: 173-8.
24.
Flint M.The menopause: reward or punishmentPsychosomatics, 1975; 16: 161-3.
25.
Beyene Y.Cultural significance and physiological manifestations of menopause. A biocultural analysisCult Med Psychiatry, 1986; 10: 47-71.
26.
Flint M., Suprapti SRCultural and subcultural meanings of the menopauseAnn N Y Acad Sci, 1990; 592: 134-48.
27.
Toit BMD.Aging and menopause among Indian South African women. New York: State University of New York Press, 1990, 1990.
28.
Klein R.Menopause malpractice: what's new about Hormone Replacement Therapy. In: Sorger R, editor. A critical look at Hormone Replacement Therapy. Melbourne: Healthsharing Productions,, 1990: 21-6.
29.
MacPherson KIMenopause as disease: the social construction of a metaphorAdv Nurs Sci, 1981; 3: 95-113.
30.
McCrea FBThe politics of menopause: the ``discovery'' of a deficiency diseaseSocial Problems, 1983 ; 31: 111-23.
31.
Worcester N. , Whatley MHThe selling of HRT: playing on the fear factorFeminist Review, 1992; 41: 1-26.
32.
Dumble LJHormone Replacement Therapy: the m(yth) of modern medicine. In: Sorger R, editor. A critical look at Hormone Replacement Therapy. Melbourne: Healthsharing Productions, 1992: 15-20.
Theisen CS, Mansfield PKMenopause: social construction or biological destiny?J Health Educ, 1993; 24: 209-13.
35.
Wren BG, Brown L.Compliance with hormonal replacement therapyMaturitas, 1991; 13: 17-21.
36.
Jolleys JV, Olesen F.A comparative study of prescribing of hormone replacement therapy in USA and EuropeMaturitas, 1996; 23: 47-53.
37.
Oddens BJ, Boulet MJ, Lehert P., Visser APHas the climacteric been medicalised? A study on the use of medication for climacteric complaints in four countriesMaturitas, 1992; 15: 171-81.
38.
Oddens BJ, Boulet MJ, Lehert P., Visser APA study on the use of medication for climacteric complaints in Western Europe. IIMaturitas, 1994; 19: 1-12.
39.
Shelley JM, Smith A., Dudley E., Dennerstein L.Use of hormone replacement therapy by Melbourne womenAust J Public Health, 1995; 19: 387-92.
40.
MacLennan AH , MacLennan A., Wilson D.The prevalence of oestrogen replacement therapy in South AustraliaMaturitas, 1993; 16: 175-83.
41.
Mattson LA, Stadberg E., Milsom I.Management of hormone replacement therapy: the Swedish experienceEur J Obstet Gynecol Reprod Biol, 1996; 64: S3-5.
42.
Olesen C., Steffensen FH, Sorensen HT, Nielsen GL, Olsen J., Bergman U.Low use of long-term hormone replacement therapy in DenmarkBr J Clin Pharmacol, 1999; 47: 323-8.
43.
Sogaard AJ, Fonnebo V., Magnus JH, Tollan A.Hormone replacement therapy among Norwegian women. Self-reported use and sales of estrogen preparationsTidsskr Nor Laegeforen, 1998; 118: 590-5.
